Percent atheroma volume: Optimal variable to report whole-heart atherosclerotic plaque burden with coronary CTA, the PARADIGM study.


Journal

Journal of cardiovascular computed tomography
ISSN: 1876-861X
Titre abrégé: J Cardiovasc Comput Tomogr
Pays: United States
ID NLM: 101308347

Informations de publication

Date de publication:
Historique:
received: 20 08 2019
revised: 05 11 2019
accepted: 29 01 2020
pubmed: 18 2 2020
medline: 7 10 2020
entrez: 18 2 2020
Statut: ppublish

Résumé

Different methodologies to report whole-heart atherosclerotic plaque on coronary computed tomography angiography (CCTA) have been utilized. We examined which of the three commonly used plaque burden definitions was least affected by differences in body surface area (BSA) and sex. The PARADIGM study includes symptomatic patients with suspected coronary atherosclerosis who underwent serial CCTA >2 years apart. Coronary lumen, vessel, and plaque were quantified from the coronary tree on a 0.5 mm cross-sectional basis by a core-lab, and summed to per-patient. Three quantitative methods of plaque burden were employed: (1) total plaque volume (PV) in mm The study population comprised 1479 patients (age 60.7 ± 9.3 years, 58.4% male) who underwent CCTA. A total of 17,649 coronary artery segments were evaluated with a median of 12 (IQR 11-13) segments per-patient (from a 16-segment coronary tree). Patients with a large BSA (top quartile), compared with the remaining patients, had a larger PV and TAV PAV was less affected by patient's body surface area then PV and TAV

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Different methodologies to report whole-heart atherosclerotic plaque on coronary computed tomography angiography (CCTA) have been utilized. We examined which of the three commonly used plaque burden definitions was least affected by differences in body surface area (BSA) and sex.
METHODS METHODS
The PARADIGM study includes symptomatic patients with suspected coronary atherosclerosis who underwent serial CCTA >2 years apart. Coronary lumen, vessel, and plaque were quantified from the coronary tree on a 0.5 mm cross-sectional basis by a core-lab, and summed to per-patient. Three quantitative methods of plaque burden were employed: (1) total plaque volume (PV) in mm
RESULTS RESULTS
The study population comprised 1479 patients (age 60.7 ± 9.3 years, 58.4% male) who underwent CCTA. A total of 17,649 coronary artery segments were evaluated with a median of 12 (IQR 11-13) segments per-patient (from a 16-segment coronary tree). Patients with a large BSA (top quartile), compared with the remaining patients, had a larger PV and TAV
CONCLUSIONS CONCLUSIONS
PAV was less affected by patient's body surface area then PV and TAV

Identifiants

pubmed: 32063545
pii: S1934-5925(19)30459-9
doi: 10.1016/j.jcct.2020.01.012
pii:
doi:

Types de publication

Comparative Study Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

400-406

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest Dr. James K. Min receives funding from the Dalio Foundation, National Institutes of Health, and GE Healthcare. Dr. Min serves on the scientific advisory board of Arineta and GE Healthcare, and has an equity interest in Cleerly. Dr. Habib Samady serves on the scientific advisory board of Philips, has equity interest in Covanos Inc., and has a research grant from Medtronic. Dr. Kavitha Chinnaiyan is a non-compensated medical advisory board member of Heartflow Inc. The remaining authors have no relevant disclosures.

Auteurs

Alexander R van Rosendael (AR)

Department of Radiology, NewYork-Presbyterian Hospital and Weill Cornell Medicine, New York, NY, USA; Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.

Fay Y Lin (FY)

Department of Radiology, NewYork-Presbyterian Hospital and Weill Cornell Medicine, New York, NY, USA.

Xiaoyue Ma (X)

Department of Healthcare Policy and Research, New York-Presbyterian Hospital and the Weill Cornell Medical College, New York, NY, USA.

Inge J van den Hoogen (IJ)

Department of Radiology, NewYork-Presbyterian Hospital and Weill Cornell Medicine, New York, NY, USA; Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.

Umberto Gianni (U)

Department of Radiology, NewYork-Presbyterian Hospital and Weill Cornell Medicine, New York, NY, USA; Department of Molecular Medicine, Section of Cardiology, University of Pavia, Pavia, Italy.

Omar Al Hussein (O)

Department of Radiology, NewYork-Presbyterian Hospital and Weill Cornell Medicine, New York, NY, USA.

Subhi J Al'Aref (SJ)

Department of Radiology, NewYork-Presbyterian Hospital and Weill Cornell Medicine, New York, NY, USA.

Jessica M Peña (JM)

Department of Radiology, NewYork-Presbyterian Hospital and Weill Cornell Medicine, New York, NY, USA.

Daniele Andreini (D)

Centro Cardiologico Monzino, IRCCS Milan, Italy.

Mouaz H Al-Mallah (MH)

Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, TX, USA.

Matthew J Budoff (MJ)

Department of Medicine, Los Angeles Biomedical Research Institute, Torrance, CA, USA.

Filippo Cademartiri (F)

Cardiovascular Imaging Center, SDN IRCCS, Naples, Italy.

Kavitha Chinnaiyan (K)

Department of Cardiology, William Beaumont Hospital, Royal Oak, MI, USA.

Jung Hyun Choi (JH)

Pusan University Hospital, Busan, South Korea.

Edoardo Conte (E)

Centro Cardiologico Monzino, IRCCS Milan, Italy.

Hugo Marques (H)

UNICA, Unit of Cardiovascular Imaging, Hospital da Luz, Lisboa, Portugal.

Pedro de Araújo Gonçalves (P)

UNICA, Unit of Cardiovascular Imaging, Hospital da Luz, Lisboa, Portugal.

Ilan Gottlieb (I)

Department of Radiology, Casa de Saude São Jose, Rio de Janeiro, Brazil.

Martin Hadamitzky (M)

Department of Radiology and Nuclear Medicine, German Heart Center Munich, Munich, Germany.

Jonathon A Leipsic (JA)

Department of Medicine and Radiology, University of British Columbia, Vancouver, BC, Canada.

Erica Maffei (E)

Department of Radiology, Area Vasta 1/ASUR Marche, Urbino, Italy.

Gianluca Pontone (G)

Centro Cardiologico Monzino, IRCCS Milan, Italy.

Gilbert L Raff (GL)

Department of Cardiology, William Beaumont Hospital, Royal Oak, MI, USA.

Sanghoon Shin (S)

Division of Cardiology, Department of Internal Medicine, Ewha Womans University Seoul Hospital, Seoul, South Korea.

Yong-Jin Kim (YJ)

Department of Internal Medicine, Seoul National University College of Medicine, Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea.

Byoung Kwon Lee (BK)

Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.

Eun Ju Chun (EJ)

Seoul National University Bundang Hospital, Sungnam, South Korea.

Ji Min Sung (JM)

Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea; Yonsei-Cedars-Sinai Integrative Cardiovascular Imaging Research Center, Yonsei University College of Medicine, Yonsei University Health System, South Korea.

Sang-Eun Lee (SE)

Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea; Yonsei-Cedars-Sinai Integrative Cardiovascular Imaging Research Center, Yonsei University College of Medicine, Yonsei University Health System, South Korea.

Daniel S Berman (DS)

Department of Imaging and Medicine, Cedars Sinai Medical Center, Los Angeles, CA, USA.

Renu Virmani (R)

Department of Pathology, CVPath Institute, Gaithersburg, MD, USA.

Habib Samady (H)

Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.

Peter H Stone (PH)

Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Jagat Narula (J)

Icahn School of Medicine at Mount Sinai, Mount Sinai Heart, Zena and Michael A. Wiener Cardiovascular Institute, Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, New York, NY, USA.

Jeroen J Bax (JJ)

Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.

Leslee J Shaw (LJ)

Department of Radiology, NewYork-Presbyterian Hospital and Weill Cornell Medicine, New York, NY, USA.

James K Min (JK)

Department of Radiology, NewYork-Presbyterian Hospital and Weill Cornell Medicine, New York, NY, USA. Electronic address: jkm2001@med.cornell.edu.

Hyuk-Jae Chang (HJ)

Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH